Loss of ninein interferes with osteoclast formation and causes premature ossification

Abstract

Ninein is a centrosome protein that has been implicated in microtubule anchorage and centrosome cohesion. Mutations in the human NINEIN gene have been linked to Seckel syndrome and to a rare form of skeletal dysplasia. However, the role of ninein in skeletal development remains unknown. Here, we describe a ninein knockout mouse with advanced endochondral ossification during embryonic development. Although the long bones maintain a regular size, the absence of ninein delays the formation of the bone marrow cavity in the prenatal tibia. Likewise, intramembranous ossification in the skull is more developed, leading to a premature closure of the interfrontal suture. We demonstrate that ninein is strongly expressed in osteoclasts of control mice, and that its absence reduces the fusion of precursor cells into syncytial osteoclasts, whereas the number of osteoblasts remains unaffected. As a consequence, ninein-deficient osteoclasts have a reduced capacity to resorb bone. At the cellular level, the absence of ninein interferes with centrosomal microtubule organization, reduces centrosome cohesion, and provokes the loss of centrosome clustering in multinucleated mature osteoclasts. We propose that centrosomal ninein is important for osteoclast fusion, to enable a functional balance between bone-forming osteoblasts and bone-resorbing osteoclasts during skeletal development.

Data availability

10.6084/m9.figshare.25650942source data files have been provided for Figure 7-figure supplement 1

The following data sets were generated

Article and author information

Author details

  1. Thierry Gilbert

    Centre de Biologie Intégrative, University Toulouse III, CNRS, Toulouse, France
    Competing interests
    The authors declare that no competing interests exist.
  2. Camille Gorlt

    Centre de Biologie Intégrative, University Toulouse III, CNRS, Toulouse, France
    Competing interests
    The authors declare that no competing interests exist.
  3. Merlin Barbier

    Centre de Biologie Intégrative, University Toulouse III / CNRS, Toulouse, France
    Competing interests
    The authors declare that no competing interests exist.
  4. Benjamin Duployer

    CIRIMAT, University Toulouse III, CNRS, Toulouse, France
    Competing interests
    The authors declare that no competing interests exist.
  5. Marianna Plozza

    Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, UPS, Toulouse, France
    Competing interests
    The authors declare that no competing interests exist.
  6. Ophélie Dufrancais

    Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, UPS, Toulouse, France
    Competing interests
    The authors declare that no competing interests exist.
  7. Laure-Elene Martet

    Centre de Biologie Intégrative, University Toulouse III, CNRS, Toulouse, France
    Competing interests
    The authors declare that no competing interests exist.
  8. Elisa Dalbard

    Centre de Biologie Intégrative, University Toulouse III, CNRS, Toulouse, France
    Competing interests
    The authors declare that no competing interests exist.
  9. Loelia Segot

    Centre de Biologie Intégrative, University Toulouse III, CNRS, Toulouse, France
    Competing interests
    The authors declare that no competing interests exist.
  10. Christophe Tenailleau

    CIRIMAT, University Toulouse III, CNRS, Toulouse, France
    Competing interests
    The authors declare that no competing interests exist.
  11. Laurence Haren

    Centre de Biologie Intégrative, University Toulouse III, CNRS, Toulouse, France
    Competing interests
    The authors declare that no competing interests exist.
  12. Christel Vérollet

    Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, UPS, Toulouse, France
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1079-9085
  13. Christiane Bierkamp

    Centre de Biologie Intégrative, University Toulouse III, CNRS, Toulouse, France
    Competing interests
    The authors declare that no competing interests exist.
  14. Andreas Merdes

    Centre de Biologie Intégrative, University Toulouse III, CNRS, Toulouse, France
    For correspondence
    andreas.merdes@univ-tlse3.fr
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3739-2728

Funding

Agence Nationale de la Recherche (ANR16-CE13-0005-01)

  • Christel Vérollet

Universite Toulouse III (financement S&N Bernard)

  • Andreas Merdes

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All animal experiments were approved by the Institutional Animal Care and Use Committee at the Genotoul Anexplo facilities of the Center for Integrative Biology, University Toulouse III (institution agreement #D3155511, project agreement APAFIS#2725-2015111213203624 v5).

Copyright

© 2024, Gilbert et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 456
    views
  • 106
    downloads
  • 2
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Thierry Gilbert
  2. Camille Gorlt
  3. Merlin Barbier
  4. Benjamin Duployer
  5. Marianna Plozza
  6. Ophélie Dufrancais
  7. Laure-Elene Martet
  8. Elisa Dalbard
  9. Loelia Segot
  10. Christophe Tenailleau
  11. Laurence Haren
  12. Christel Vérollet
  13. Christiane Bierkamp
  14. Andreas Merdes
(2024)
Loss of ninein interferes with osteoclast formation and causes premature ossification
eLife 13:e93457.
https://doi.org/10.7554/eLife.93457

Share this article

https://doi.org/10.7554/eLife.93457

Further reading

    1. Developmental Biology
    2. Stem Cells and Regenerative Medicine
    Thi Thom Mac, Teddy Fauquier ... Thierry Brue
    Research Article

    Deficient Anterior pituitary with common Variable Immune Deficiency (DAVID) syndrome results from NFKB2 heterozygous mutations, causing adrenocorticotropic hormone deficiency (ACTHD) and primary hypogammaglobulinemia. While NFKB signaling plays a crucial role in the immune system, its connection to endocrine symptoms is unclear. We established a human disease model to investigate the role of NFKB2 in pituitary development by creating pituitary organoids from CRISPR/Cas9-edited human induced pluripotent stem cells (hiPSCs). Introducing homozygous TBX19K146R/K146R missense pathogenic variant in hiPSC, an allele found in congenital isolated ACTHD, led to a strong reduction of corticotrophs number in pituitary organoids. Then, we characterized the development of organoids harboring NFKB2D865G/D865G mutations found in DAVID patients. NFKB2D865G/D865G mutation acted at different levels of development with mutant organoids displaying changes in the expression of genes involved on pituitary progenitor generation (HESX1, PITX1, LHX3), hypothalamic secreted factors (BMP4, FGF8, FGF10), epithelial-to-mesenchymal transition, lineage precursors development (TBX19, POU1F1) and corticotrophs terminal differentiation (PCSK1, POMC), and showed drastic reduction in the number of corticotrophs. Our results provide strong evidence for the direct role of NFKB2 mutations in the endocrine phenotype observed in patients leading to a new classification of a NFKB2 variant of previously unknown clinical significance as pathogenic in pituitary development.

    1. Developmental Biology
    2. Genetics and Genomics
    Debashish U Menon, Prabuddha Chakraborty ... Terry Magnuson
    Research Article

    We present evidence implicating the BAF (BRG1/BRM Associated Factor) chromatin remodeler in meiotic sex chromosome inactivation (MSCI). By immunofluorescence (IF), the putative BAF DNA binding subunit, ARID1A (AT-rich Interaction Domain 1 a), appeared enriched on the male sex chromosomes during diplonema of meiosis I. Germ cells showing a Cre-induced loss of ARID1A arrested in pachynema and failed to repress sex-linked genes, indicating a defective MSCI. Mutant sex chromosomes displayed an abnormal presence of elongating RNA polymerase II coupled with an overall increase in chromatin accessibility detectable by ATAC-seq. We identified a role for ARID1A in promoting the preferential enrichment of the histone variant, H3.3, on the sex chromosomes, a known hallmark of MSCI. Without ARID1A, the sex chromosomes appeared depleted of H3.3 at levels resembling autosomes. Higher resolution analyses by CUT&RUN revealed shifts in sex-linked H3.3 associations from discrete intergenic sites and broader gene-body domains to promoters in response to the loss of ARID1A. Several sex-linked sites displayed ectopic H3.3 occupancy that did not co-localize with DMC1 (DNA meiotic recombinase 1). This observation suggests a requirement for ARID1A in DMC1 localization to the asynapsed sex chromatids. We conclude that ARID1A-directed H3.3 localization influences meiotic sex chromosome gene regulation and DNA repair.